Few prostate cancer guidelines are of high methodologic quality and therefore trustworthy
Canadian Urological Association Journal · 20.08.2026 · 20 (12)
DOI: 10.5489/cuaj.9674 ↗Kurz gefasst
Leitlinie in der Zeitschrift Canadian Urological Association Journal, online erschienen am 20.08.2026. Verfasst von Farhad Tondroanamag und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Abstract (Originalsprache)
Introduction
Prostate cancer is the most common malignancy among men worldwide, underscoring the importance of high-quality, evidence-based clinical practice guidelines (CPGs) in this field. We conducted this study to evaluate the methodologic quality of prostate cancer CPGs.
Methods
Following a prespecified protocol, we conducted a cross-sectional study of English-language prostate cancer CPGs published between 2014 and 2024, searching Medline (Ovid), Trip, EMBASE, ECRI, Guidelines International Network, and Guidelines Central databases. We included guidelines covering screening, diagnosis, and/or management of prostate cancer. Two reviewers independently applied the modified National Guideline Clearinghouse Extent of Adherence to Trustworthy Standards (NEATS) instrument, consisting of 10 items and generating summary scores from 10 (lowest) to 50 (highest) points. Guidelines were categorized as low- (≤16), intermediate- (17–31), or high-quality (≥32).
Results
Of 1005 references screened, 23 international guidelines met the inclusion criteria. Only six CPGs (26%) were rated high-quality; over one-third (8/23, 34.7%) were categorized as low-quality. Most CPGs inadequately reported conflicts of interest, multidisciplinary panel composition, or systematic review methods underpinning recommendations. No significant associations were observed between guideline quality and year of publication or breadth of scope.
Conclusions
Most prostate cancer CPGs published in English demonstrate limited methodologic rigor, not meeting National Academy of Medicine standards for trustworthy guidelines. Guideline users should critically appraise these documents prior to implementation, and developers are encouraged to adopt established frameworks, such as GRADE, to improve quality.
Autor:innen und Institutionen
- Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Department of Urology, Clínica Universidad de Navarra, Madrid, Spain.
- Dr. John Archer Library, University of Regina, Regina, SK, Canada.
- Minneapolis Veterans Affairs Health Care System, Urology Section, Minneapolis, MN, United States.
- University of Minnesota, Department of Urology, Minneapolis, MN, United States.
Zitieren
APA
Tondroanamag, F., Gonzalez-Padilla, D. A., Bakker, C., & Dahm, P. (2026). Few prostate cancer guidelines are of high methodologic quality and therefore trustworthy. Canadian Urological Association Journal, 20(12). https://doi.org/10.5489/cuaj.9674
Vancouver
Tondroanamag F, Gonzalez-Padilla DA, Bakker C, Dahm P. Few prostate cancer guidelines are of high methodologic quality and therefore trustworthy. Canadian Urological Association Journal. 2026;20(12). doi:10.5489/cuaj.9674
BibTeX
@article{Tondroanamag2026,
author = {Tondroanamag, Farhad and Gonzalez-Padilla, Daniel A and Bakker, Caitlin and Dahm, Philipp},
title = {Few prostate cancer guidelines are of high methodologic quality and therefore trustworthy},
journal = {Canadian Urological Association Journal},
year = {2026},
volume = {20},
number = {12},
doi = {10.5489/cuaj.9674}
}
EUVIMED